Catalyst Pharmaceuticals To Present Firdapse Phase 3 Trial Results At The 61st Annual Meeting Of The American Association Of Neuromuscular And Electrodiagnostic Medicine
October 27, 2014 at 08:11 AM EDT
Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) (Catalyst Pharmaceuticals), a biopharmaceutical company focused on developing and ...
